Stockscreener 앱 받기
6.03
14.64%
0.77
전일 마감가:
$5.26
열려 있는:
$5.27
하루 거래량:
16.49M
Relative Volume:
3.68
시가총액:
$590.86M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+7.49%
1개월 성능:
+15.30%
6개월 성능:
+69.86%
1년 성능:
+222.46%
1일 변동 폭
$5.22
$6.50
1주일 범위
$5.08
$6.50
52주 변동 폭
$1.67
$7.2904
Atyr Pharma Inc Stock (ATYR) Company Profile
명칭
Atyr Pharma Inc
전화
(858) 731-8389
주소
10240 SORRENTO VALLEY ROAD, SAN DIEGO
ATYR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATYR
Atyr Pharma Inc
|
6.03 | 513.45M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Atyr Pharma Inc Stock (ATYR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-18 | 개시 | Leerink Partners | Outperform |
| 2025-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-04 | 개시 | Wells Fargo | Overweight |
| 2024-09-05 | 개시 | Jefferies | Buy |
| 2023-07-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-10-12 | 개시 | RBC Capital Mkts | Outperform |
| 2021-09-21 | 개시 | Piper Sandler | Overweight |
| 2021-05-10 | 개시 | Laidlaw | Buy |
| 2020-08-17 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | 개시 | ROTH Capital | Buy |
| 2020-03-02 | 개시 | Oppenheimer | Outperform |
| 2018-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-07 | 개시 | Piper Jaffray | Overweight |
| 2016-12-13 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-12-16 | 개시 | Citigroup | Neutral |
| 2015-06-01 | 개시 | Citigroup | Buy |
| 2015-06-01 | 개시 | JP Morgan | Overweight |
모두보기
Atyr Pharma Inc 주식(ATYR)의 최신 뉴스
1 Small-Cap Biotech Stock Poised for a Breakout - MSN
American Century Companies Inc. Sells 65,409 Shares of aTyr Pharma, Inc. $ATYR - MarketBeat
Cantor Fitzgerald reiterates Overweight rating on aTyr Pharma stock - Investing.com
aTyr Pharma, Inc. (NASDAQ:ATYR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Octagon Capital Advisors LP Acquires 2,652,000 Shares of aTyr Pharma, Inc. $ATYR - MarketBeat
Lead Therapy Trial Fuels aTyr Pharma’s (ATYR) Promising Upside, Leerink Stays Bullish - uk.finance.yahoo.com
Can aTyr Pharma Inc. weather a recessionDip Buying & Safe Entry Point Identification - Lancaster City Council
aTyr Pharma Inc put volume heavy and directionally bearish - TipRanks
Is Summit Therapeutics a Buy, Sell, or Hold Now? - AOL.com
Investors Purchase Large Volume of aTyr Pharma Put Options (NASDAQ:ATYR) - MarketBeat
Jefferies Raises Price Target for aTyr Pharma (ATYR) Ahead of Study Results - MSN
aTyr Pharma (NASDAQ:ATYR) Trading Up 8.1%Should You Buy? - MarketBeat
Multi asset correlation models including aTyr Pharma Inc.Weekly Risk Summary & Growth Focused Stock Reports - Newser
When is the best time to exit aTyr Pharma Inc.July 2025 News Drivers & Consistent Growth Stock Picks - Newser
168,742 Shares in aTyr Pharma, Inc. $ATYR Acquired by Wellington Management Group LLP - MarketBeat
How a Surge in Bearish Options Activity at aTyr Pharma (ATYR) Has Changed Its Investment Story - simplywall.st
Does aTyr Pharma Inc. qualify in momentum factor screeningMarket Movement Recap & Step-by-Step Trade Execution Guides - Newser
aTyr Pharma Inc. stock daily chart insightsEarnings Risk Summary & High Accuracy Trade Signal Alerts - Newser
Price momentum metrics for aTyr Pharma Inc. explainedEarnings Performance Report & AI Powered Market Entry Strategies - Newser
Is aTyr Pharma Inc. a play on infrastructure spendingJuly 2025 Outlook & Fast Moving Stock Trade Plans - خودرو بانک
Employee Equity Incentives and Biotech Valuation: How aTyr Pharma’s Inducement Grants Align with Pipeline Progress - AInvest
Is aTyr Pharma Inc. forming bullish engulfing patternsMarket Sentiment Review & Precise Trade Entry Recommendations - خودرو بانک
What is aTyr Pharma Inc.’s book value per shareQuarterly Trade Report & Fast Momentum Stock Entry Tips - خودرو بانک
We're Hopeful That ATyr Pharma (NASDAQ:ATYR) Will Use Its Cash Wisely - 富途牛牛
Using AI based signals to follow aTyr Pharma Inc.Global Markets & High Accuracy Swing Entry Alerts - Newser
Published on: 2025-09-06 02:07:40 - خودرو بانک
ATyr Pharma's Strategic Talent Retention and Pipeline Momentum Signal Long-Term Value Creation - AInvest
ATyr Pharma announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ATYR Stock News - GuruFocus
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biotech aTyr Pharma Awards 62,400 Shares to New Employees for Novel tRNA Drug Development Program - Stock Titan
Is aTyr Pharma Inc.’s ROE strong enough2025 Market WrapUp & Safe Entry Trade Reports - خودرو بانک
Can aTyr Pharma Inc. rally from current levels2025 Key Highlights & Weekly High Return Opportunities - Newser
Tick level data insight on aTyr Pharma Inc. volatility2025 Trade Ideas & Real-Time Chart Breakout Alerts - Newser
Block Trades: Is aTyr Pharma Inc. exposed to political riskJuly 2025 Snapshot & Weekly Stock Performance Updates - خودرو بانک
What data driven models say about aTyr Pharma Inc.’s futureProfit Target & Fast Moving Trade Plans - Newser
Visualizing aTyr Pharma Inc. stock with heatmaps2025 Top Decliners & Safe Capital Growth Tips - Newser
Using fundamentals and technicals on aTyr Pharma Inc.Portfolio Value Report & Weekly Momentum Picks - Newser
aTyr Pharma Inc.’s volatility index tracking explainedWeekly Trend Summary & Real-Time Stock Movement Alerts - Newser
Will breakout in aTyr Pharma Inc. lead to full recoveryJuly 2025 Setups & Safe Capital Growth Stock Tips - Newser
aTyr Pharma’s Sharp Intraday Drop: What’s Behind the Move? - AInvest
Volatility clustering patterns for aTyr Pharma Inc.July 2025 PreEarnings & AI Enhanced Trade Execution Alerts - Newser
Heatmap analysis for aTyr Pharma Inc. and competitors2025 Risk Factors & Long-Term Growth Portfolio Plans - Newser
Aug Rallies: Is aTyr Pharma Inc.’s ROE strong enoughInsider Buying & Community Verified Trade Signals - خودرو بانک
Is aTyr Pharma Inc. exposed to political riskMarket Risk Report & Daily Growth Stock Investment Tips - خودرو بانک
Atyr Pharma Inc (ATYR) 재무 분석
Atyr Pharma Inc (ATYR)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Atyr Pharma Inc 주식 (ATYR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Broadfoot Jill Marie | Chief Financial Officer |
Feb 04 '25 |
Sale |
3.78 |
1,254 |
4,740 |
31,763 |
| DENYES NANCY | General Counsel |
Feb 04 '25 |
Sale |
3.78 |
899 |
3,398 |
26,555 |
0.93%
0.10%
자본화:
|
볼륨(24시간):